R87.624 Abrechenbarer, spezifischer Code Cytologic evidence of malignancy on smear of vagina
ICD-10-CM R87.624 identifies “Cytologic evidence of malignancy on smear of vagina” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Kapitel 18: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Hinweise zum Code
Keine zusätzlichen Hinweise.
Hinweise übergeordneter Ebenen
R87.62 · Abnormal cytological findings in specimens from vagina
Excludes 18
- abnormal cytological findings in specimens from cervix uteri (R87.61-)
- abnormal cytological findings in specimens from other female genital organs (R87.69)
- carcinoma in situ of vagina (histologically confirmed) (D07.2)
- vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
- vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
- vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
- dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
- severe dysplasia of vagina (histologically confirmed) (D07.2)
Excludes 22
Use additional code1
code to identify acquired absence of uterus and cervix, if applicable (Z90.71-)
Kapitel 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)
Excludes 24
Note9
- This chapter includes symptoms, signs, abnormal results of clinical or other investigative procedures, and ill-defined conditions regarding which no diagnosis classifiable elsewhere is recorded.
- Signs and symptoms that point rather definitely to a given diagnosis have been assigned to a category in other chapters of the classification. In general, categories in this chapter include the less well-defined conditions and symptoms that, without the necessary study of the case to establish a final diagnosis, point perhaps equally to two or more diseases or to two or more systems of the body. Practically all categories in the chapter could be designated 'not otherwise specified', 'unknown etiology' or 'transient'. The Alphabetical Index should be consulted to determine which symptoms and signs are to be allocated here and which to other chapters. The residual subcategories, numbered .8, are generally provided for other relevant symptoms that cannot be allocated elsewhere in the classification.
- The conditions and signs or symptoms included in categories R00-R94 consist of:
- (a) cases for which no more specific diagnosis can be made even after all the facts bearing on the case have been investigated;
- (b) signs or symptoms existing at the time of initial encounter that proved to be transient and whose causes could not be determined;
- (c) provisional diagnosis in a patient who failed to return for further investigation or care;
- (d) cases referred elsewhere for investigation or treatment before the diagnosis was made;
- (e) cases in which a more precise diagnosis was not available for any other reason;
- (f) certain symptoms, for which supplementary information is provided, that represent important problems in medical care in their own right.
R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)
Excludes 12
- abnormal findings on antenatal screening of mother (O28.-)
- diagnostic abnormal findings classified elsewhere - see Alphabetical Index
Excludes 23
- abnormal findings on examination of blood, without diagnosis (R70-R79)
- abnormal findings on examination of urine, without diagnosis (R80-R82)
- abnormal tumor markers (R97.-)
R87 · Abnormal findings in specimens from female genital organs
Includes3
- abnormal findings in secretion and smears from cervix uteri
- abnormal findings in secretion and smears from vagina
- abnormal findings in secretion and smears from vulva
Verweise im offiziellen Index
Verweise im offiziellen Index (2)
Abnormal, abnormality, abnormalities (1)
Evidence (1)
- Evidence › cytologic › of malignancy on vaginal smearKrankheitsverzeichnis
Verlauf
Codeverlauf
Keine Änderung seit der ersten Erfassung
GeändertUnverändert
FY2016
Gültig ab
- Erstmals erfasst
Cytologic evidence of malignancy on smear of vagina
Abrechenbarer Diagnosecode
CDC/NCHS · FY2016Alle Ausgaben (19)
| Alle Ausgaben | Gültig ab | Codeverlauf |
|---|---|---|
| FY2016 | 2015-10-01 | Erstmals erfasst |
| FY2017 | 2016-10-01 | Keine tabellarische Änderung |
| FY2018 | 2017-10-01 | Keine tabellarische Änderung |
| FY2019 | 2018-10-01 | Keine tabellarische Änderung |
| FY2020 | 2019-10-01 | Keine tabellarische Änderung |
| FY2020 · April | 2020-04-01 | Keine tabellarische Änderung |
| FY2021 | 2020-10-01 | Keine tabellarische Änderung |
| FY2021 · 01-01 | 2021-01-01 | Keine tabellarische Änderung |
| FY2022 | 2021-10-01 | Keine tabellarische Änderung |
| FY2022 · 04-01 | 2022-04-01 | Keine tabellarische Änderung |
| FY2023 | 2022-10-01 | Keine tabellarische Änderung |
| FY2023 · 04-01 | 2023-04-01 | Keine tabellarische Änderung |
| FY2024 | 2023-10-01 | Keine tabellarische Änderung |
| FY2024 · 04-01 | 2024-04-01 | Keine tabellarische Änderung |
| FY2025 | 2024-10-01 | Keine tabellarische Änderung |
| FY2025 · 04-01 | 2025-04-01 | Keine tabellarische Änderung |
| FY2026 | 2025-10-01 | Keine tabellarische Änderung |
| FY2026 · April | 2026-04-01 | Keine tabellarische Änderung |
| FY2027 | 2026-10-01 | Keine tabellarische Änderung |
Historische ICD-9-Zuordnungen · 2018
Nur historische Zuordnung; kein automatischer Codeersatz.
- 795.16
Dieser Eintrag ist ein vollständiger Code in der gewählten Ausgabe. Die Referenzprüfung bestätigt keine klinische Eignung und garantiert keine Erstattung.